IPM- Indian Pharmaceutical Market

IPM has been now valued at 72,069 cr. as against 65,658 cr. in 2012. Pharmaceutical sector witnessed the lower growth rate of 9.8% as compared to 16.6% in 2012. the slowdown is due to the New drug policy and the regulatory interventions over last year.additional challenges are Delay in clinical trials, uncertainties over FDI policy, compulsary licensing. new product launches in 2012 are 1700. Chronic therapies market(cardio,gastro,CNS, Diabetic) has gone up to 30% in 2013.